BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15041312)

  • 1. Impact of cyclosporine in the development of immunosuppressive therapy.
    Chaverri C
    Transplant Proc; 2004 Mar; 36(2 Suppl):80S-82S. PubMed ID: 15041312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression in kidney transplantation in Poland.
    Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
    Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical immunosuppressive matrix in organ transplantation.
    Land W
    Transplant Proc; 1994 Oct; 26(5):2479-84. PubMed ID: 7940762
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine in renal transplantation: a Scottish experience.
    Jardine AG; Geddes CC
    Transplant Proc; 2004 Mar; 36(2 Suppl):139S-142S. PubMed ID: 15041324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cyclosporine on the development of immunosuppressive therapy.
    Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2004 Mar; 36(2 Suppl):130S-134S. PubMed ID: 15041322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years' experience with cyclosporine monotherapy after renal transplantation.
    Hillebrand G; Schneeberger H; Schleibner S; Krumme D; Hillebrand C; Burkhardt K; Hacker H; Illner WD; Land W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):513-4. PubMed ID: 8438395
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine.
    Hoyer PF; Vester U
    Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with therapeutic drug monitoring of cyclosporine.
    Abendroth D
    Transplant Proc; 2004 Mar; 36(2 Suppl):426S-429S. PubMed ID: 15041379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future directions in immunosuppression.
    Beckebaum S; Cicinnati VR; Broelsch CE
    Transplant Proc; 2004 Mar; 36(2 Suppl):574S-576S. PubMed ID: 15041408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of cyclosporine in renal transplantation: experience at the University of Padua.
    Furian L; Baldan N; Rigotti P
    Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac transplant experience with cyclosporine.
    Patel JK; Kobashigawa JA
    Transplant Proc; 2004 Mar; 36(2 Suppl):323S-330S. PubMed ID: 15041362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the pharmacokinetics of cyclosporine in patients following long-term administration after a kidney transplant: comparison of Neoral and Sandimmune.
    Takahara S; Ichimaru N; Kojima Y; Namba Y; Toki K; Shi Y; Yoshimura K; Matsumiya K; Nonomura N; Okuyama A
    Transplant Proc; 2004 Mar; 36(2 Suppl):456S-460S. PubMed ID: 15041387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
    Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
    Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of immunosuppression in kidney transplantation: the Ohio State University experience.
    Rajab A; Pelletier RP; Henry ML; Elkhammas EA; Bumgardner GL; Davies EA; Orosz CG; Ferguson RM
    Clin Transpl; 2005; ():111-7. PubMed ID: 17424729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cyclosporine on the development of immunosuppressive therapy.
    Haberal M; Emiroglu R; DalgiƧ A; Karakayli H; Moray G; Bilgin N
    Transplant Proc; 2004 Mar; 36(2 Suppl):143S-147S. PubMed ID: 15041325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.